2018 International Congress

October 5-9, 2018. Hong Kong. Abstracts are presented on the 6th, 7th, and 8th.

View by Title View Sessions

View by Date

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Cognitive impairment in multiple system atrophy: A Nepalese tertiary center study

R. Ojha, K. Oli (Kathmandu, Nepal)
Cognitive networks in Parkinson’s Disease Mild Cognitive Impairment: Salience Network disruption without gray matter loss

I. Aracil, F. Sampedro, J. Marin, J. Perez, H. Bejr-Kasem, S. Martinez-Horta, A. Horta, M. Boti, J. Pagonabarraga, J. Kulisevsky (Barcelona, Spain)
Cognitive Reserve and Physical Activity Modulate Functional Brain Re-organisation in Premanifest Huntington’s Disease: Preliminary Evidence

M. Soloveva, S. Jamadar, G. Poudel, N. Georgiou-Karistianis (Melbourne, Australia)
Cohort profile of the Japan Dystonia Consortium: Genetic diagnosis and characteristics of movement disorders in Japan

T. Kawarai, R. Miyamoto, A. Orlacchio, R. Kaji (Tokushima, Japan)
Combination Therapy of Ellagic Acid and Mucuna Pruriens Seeds Extract Improves Rotenone Induced Behavioural, Oxidative and Mitochondrial Deficits in Mice Model of Parkinson’s Disease

D. Khatri (Pune, India)
Combined administration of A2A receptor antagonist and 5-HT1A/1B receptor agonist reverses neuroinflammation in the 6-OHDA model of Parkinson’s disease

A. Pinna, G. Costa, M. Serra, M. Morelli (Monserrato (CA), Italy)
Combined catechol-O-methyl-transferase inhibition and intrajejunal Levodopa infusion: A real-life single-centre experience

R.N. Taddei, V. Leta, A. Sauerbier, M. Parry, A. Podlewska, L. Hall, S. Tentis, P. Odin, W. Poewe, P. Dubois, D. van Warmelen, E.W. Lim, K.R. Chaudhuri (London, United Kingdom)
Combined EMG and endoscopy guided botulinum toxin injection of the longus capitis muscle in cervical dystonia with anterocaput

J. Michelis, F. Schuler, I. Debove, J. Müllner, L. Lachenmayer, E. Seifert (Bern, Switzerland)
Combined Neurite Orientation Dispersion and Density Imaging and Myelin Imaging Provide New Insights to White Matter Changes of the Neurocognitive-psychiatric Disorder in Parkinson’s Disease

C. Andica, K. Kamagata, T. Hatano, A. Saito, Y. Takenaka, T. Ogawa, G. Oyama, Y. Shimo, M. Hori, N. Hattori, S. Aoki (Tokyo, Japan)
Combining PET imaging and blood metabolomics data to improve machine learning models for Parkinson’s disease diagnosis

E. Glaab, A. Greuel, J.P. Trezzi, C. Jäger, Z. Hodak, L. Timmermann, M. Tittgemeyer, N. Diederich (Esch-sur-Alzette, Luxembourg)

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z